课题基金 / 基金详情

Role of microRNA in the Pathophysiology of Endometriosis

Role of microRNA in the Pathophysiology of Endometriosis
microRNA 在子宫内膜异位症病理生理学中的作用
批准号:
9248409
负责人:
Asgerally T. Fazleabas
金额:
$32.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2021-01-31

项目摘要

项目成果

Asgerally T. Fazleabas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Endometriosis, the presence of endometrial glands and stroma outside of the uterine cavity causes chronic pelvic pain and infertility. It affects 10% of women of reproductive age and 35-50% of women who are infertile. The average time for confirmed clinical diagnosis takes between 8-11 years and the molecular mechanisms associated with the pathophysiology of endometriosis still remains poorly understood. Our extensive studies over the past 20 years have characterized the causative factors and molecular changes that are involved in the early onset of disease in a baboon model of experimentally induced endometriosis. MicroRNAs (miR) which are small non-coding RNAs that regulate posttranscriptional gene regulation, have emerged as important regulators that may contribute to pathophysiology of endometriosis. Our preliminary data suggests that induction of endometriosis leads to rapid and significant changes in the expression of several miRs in the baboon. MiR-451 together with miR-144 which is expressed at the same gene locus were significantly down regulated, while miR-21 and miR-29c showed a progressive increase following induction of endometriosis in both ectopic and eutopic tissues. Similar changes have been reported in women with disease. Changes in miR expression which we hypothesize are transcriptionally induced as a consequence of the disease, are associated with the corresponding alterations of their respective target genes, YWHAZ, FKBP4, 15-PGDH and fibrosis. We propose that these changes contribute to the progression of endometriosis and altered endometrial function. To test these hypotheses, in Specific Aim 1 we propose to determine if c-Fos regulation of AP-1 sites on the miR gene promoter, epigenetic changes (methylation) and increased Dicer activity associated with endometriosis is responsible for the aberrant miR expression in the eutopic and ectopic endometrium. In Specific Aim 2 we will validate the regulation of target genes YWHAZ/β−catenin by miR-451 to promote proliferation and invasion by interacting with Yes-associated protein (YAP1). Aim 3 focuses on the mechanisms by which miR-29c regulates FKBP4 which imparts progesterone resistance and results in a blunted decidualization response. The inhibition of decidualization will be assessed by the validating the expression of decorin and insulin-like growth factor binding protein-1. Specific Aim 4 will focus on the role of miR-21 in contributing to the development of fibrosis in endometriotic lesions and its potential role in mediating COX-2 mediated inflammation. These innovative studies will contribute to our understanding of the molecular mechanisms underlying the etiology of endometriosis. The proposed aims will functionally link aberrant miR expression, induced in response to the disease, with their respective target genes that induce changes in the eutopic and ectopic endometrium that are pathologically relevant in the etiology of endometriosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Endometriotic Lesion Development by NOTCH1
  • 批准号:
    10605178
  • 项目类别:
  • 资助金额:
    $55.82万
  • 财政年份:
    2021
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
Regulation of Endometriotic Lesion Development by NOTCH1
  • 批准号:
    10379364
  • 项目类别:
  • 资助金额:
    $55.82万
  • 财政年份:
    2021
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
What is Endometriosis? Deep Phenotyping to Advance Diagnosis and Treatment
  • 批准号:
    10398896
  • 项目类别:
  • 资助金额:
    $93.41万
  • 财政年份:
    2018
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
What is Endometriosis? Deep Phenotyping to Advance Diagnosis and Treatment
  • 批准号:
    9916791
  • 项目类别:
  • 资助金额:
    $62.6万
  • 财政年份:
    2018
  • 负责人:
    Asgerally T. Fazleabas
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: